Clinical Trial Update: Primary carE PPi dEprescRibing Trial [Phase 4]

View source ↗

Summary

Phase 4 deprescribing trial at KU Leuven evaluating stopping or reducing proton pump inhibitors in patients with heartburn, dyspepsia, and gastroesophageal refl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Gastroesophageal Reflux Disease

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Heartburn, Dyspepsia | Phase 4 | Status: ACTIVE_NOT_RECRUITING